Genetic predictors of circulating 25-hydroxyvitamin D and risk of colorectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 11, 2013, Pages 2037-2046

  Hiraki, Linda T ^a   Qu, Conghui ^g   Hutter, Carolyn M ^g   Baron, John A ⁱ   Berndt, Sonja I ^j   Bézieau, Stéphane ^l   Brenner, Hermann ^m   Caan, Bette J ^o   Casey, Graham ^p   Chang Claude, Jenny ⁿ   Chanock, Stephen J ^j   Conti, David V ^p   Duggan, David ^q   Fuchs, Charles S ^b,e,f   Gallinger, Steven ^r   Giovannucci, Edward L ^a,c   Harrison, Tabitha A ^g   Hayes, Richard B ^v   Hazra, Aditi ^a,e   Henderson, Brian ^p   Hoffmeister, Michael ^m   Hopper, John L ^x   Hudson, Thomas J ^s,t   Jenkins, Mark A ^x   Küry, Sebastien ^l   Marchand, Loic Le ^y   Lemire, Mathieu ^s   Ma, Jing ^c   Manson, JoAnn E ^b,e   Nan, Hongmei ^k   Newcomb, Polly A ^g,h   Ng, Kimmie ^e,f   Potter, John D ^g,h,ab   Schoen, Robert E ^z   Schumacher, Fredrick R ^p   Seminara, Daniela ^j   Slattery, Martha L ^aa   Wactawski Wende, Jean ^w   White, Emily ^g,h   Wu, Kana ^a   Zanke, Brent W ^u   Kraft, Peter ^a   Peters, Ulrike ^g,h   Chan, Andrew T ^c,d   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CHANNING LABORATORY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g USA   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

^k UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^l NANTES UNIVERSITY HOSPITAL   (France)

^m Division of Clinical Epidemiology and Aging Research   (Germany)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o DIVISION OF RESEARCH   (United States)

^p UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^q TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^r TORONTO GENERAL HOSPITAL   (Canada)

^s ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^t UNIVERSITY OF TORONTO   (Canada)

^u UNIVERSITY OF OTTAWA   (Canada)

^v University School of Medicine   (United States)

^w UNIVERSITY AT BUFFALO   (United States)

^x UNIVERSITY OF MELBOURNE   (Australia)

^y UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^z UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^aa UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^ab MASSEY UNIVERSITY   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ARTICLE; CANCER RISK; COLON CANCER; COLORECTAL CANCER; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETICS; HUMAN; META ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECTUM CANCER; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

COLORECTAL NEOPLASMS; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VITAMIN D;

EID: 84887290647     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0209     Document Type: Article

References (76)

1. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. In: SEER cancer statistics review, 1975-2010. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2010/.
2. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk.AmJ Gastroenterol 2001;96:2992-3003.
3. Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006;59:114-24.
4. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 2007;13: 356-61.
5. Tenesa A, Theodoratou E, Din FV, Farrington SM, Cetnarskyj R, Barnetson RA, et al. Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis. Clin Cancer Res. 2010;16:3754-9.
6. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008;40:1426-35.
7. Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, Howarth K, et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 2010;42:973-7.
8. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008;40:623-30.
9. Tomlinson IP, Carvajal-Carmona LG, Dobbins SE, Tenesa A, Jones AM, Howarth K, et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet 2011;7:e1002105.
10. Kocarnik JD, Hutter CM, Slattery ML, Berndt SI, Hsu L, Duggan DJ, et al. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010;19:3131-9.
11. Hutter CM, Slattery ML, Duggan DJ, Muehling J, Curtin K, Hsu L, et al. Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer 2010;10:670.
12. Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet 2012;44:770-6.
13. Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet 2010;26:132-41.
14. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31.
15. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: A 19- year prospective study in men. Lancet 1985;1:307-9.
16. Kearney J, Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996;143:907-17.
17. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol 1993;137:1302-17.
18. Martinez ME, Giovannucci EL, Colditz GA, Stampfer MJ, Hunter DJ, Speizer FE, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 1996;88:1375-82.
19. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med 2007;32:210-6.
20. Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, Murphy SP, et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2010;19:130-4.
21. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007;99: 1120-9.
22. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. J Clin Oncol 2011;29:3775-82.
23. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.AmJ Clin Nutr 2004;80:1678S-88S.
24. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96.
25. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
26. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: An updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155:827-38.
27. Carroll C, Cooper K, Papaioannou D, Hind D, Pilgrim H, Tappenden P. Supplemental calcium in the chemoprevention of colorectal cancer: A systematic review and meta-analysis. Clin Ther 2010;32:789-803.
28. Wjst M, Altmuller J, Braig C, Bahnweg M, Andre E. A genome-wide linkage scan for 25-OH-D(3) and 1, 25-(OH)2-D3 serum levels in asthma families. J Steroid Biochem Mol Biol 2007;103:799-802.
29. Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ, et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008;88:441-7.
30. Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 2001;16:371-8.
31. Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF, D'Agostino RB Sr, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 2009;63:458-64.
32. Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, et al. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice. Clin Cancer Res 2006;12:5895-901.
33. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-45.
34. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010;376:180-8.
35. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007;39:989-94.
36. Figueiredo JC, Lewinger JP, Song C, Campbell PT, Conti DV, Edlund CK, et al. Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genomewide association study. Cancer Epidemiol Biomarkers Prev 2011;20: 758-66.
37. King IB, Satia-Abouta J, Thornquist MD, Bigler J, Patterson RE, Kristal AR, et al. Buccal cell DNA yield, quality, and collection costs: comparison of methods for large-scale studies. Cancer Epidemiol Biomarkers Prev 2002;11(10 Pt 1):1130-3.
38. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-13.
39. Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 2007;81: 1084-97.
40. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-34.
41. Hutter CM, Chang-Claude J, SlatteryML, PflugeisenBM, Lin Y, Duggan D, et al. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res 2012;72:2036-44.
42. Fortier I, Doiron D, Little J, Ferretti V, L'Heureux F, Stolk RP, et al. Is rigorous retrospective harmonization possible? Application of the DataSHaPER approach across 53 large studies. Int J Epidemiol 2011;40:1314-28.
43. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8.
44. Lee JE, Li H, Chan AT, Hollis BW, Lee IM, Stampfer MJ, et al. Circulating levels of vitamin D and colon and rectal cancer: The Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 2011;4:735-43.
45. Jiao S, Hsu L, Hutter CM, Peters U. The use of imputed values in the meta-analysis of genome-wide association studies. Genet Epidemiol 2011;35:597-605.
46. Kraft P, Zeggini E, Ioannidis JP. Replication in genome-wide association studies. Stat Sci 2009;24:561-73.
47. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: A tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007;81:559-75.
48. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
49. Tosteson TD, Buzas JS, Demidenko E, Karagas M. Power and sample size calculations for generalized regression models with covariate measurement error. Stat Med 2003;22:1069-82.
50. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: A preclinical model for human sporadic colon cancer. Carcinogenesis 2009;30:88-92.
51. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137-42.
52. Yang K, Yang W, Mariadason J, Velcich A, Lipkin M, Augenlicht L. Dietary components modify gene expression: implications for carcinogenesis. J Nutr 2005;135:2710-4.
53. Toubi E, Shoenfeld Y. The role of vitamin D in regulating immune responses. Isr Med Assoc J 2010;12:174-5.
54. Erdelyi I, Levenkova N, Lin EY, Pinto JT, Lipkin M, Quimby FW, et al. Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer. J Nutr 2009;139:2072-8.
55. Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 2000;60:2304-12.
56. Giuliano AR, Franceschi RT, Wood RJ. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 1991;285:261-9.
57. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev 2005;14:525-8.
58. Fichera A, Little N, Dougherty U, Mustafi R, Cerda S, Li YC, et al. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res 2007;142:239-45.
59. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe- Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002;95:787-96.
60. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and antiinflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011;51:311-36.
61. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85: 1586-91.
62. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1, 25-dihydroxyvitamin D: A reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 1985;61: 969-75.
63. Chun RF. New perspectives on the vitamin D binding protein. Cell Biochem Funct 2012;30:445-56.
64. Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, Ankers E, et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 2011;26:1609-16.
65. Bhan I, Powe CE, Berg AH, Ankers E, Wenger JB, Karumanchi SA, et al. Bioavailable vitaminDis more tightly linked to mineral metabolismthan total vitamin D in incident hemodialysis patients. Kidney Int 2012;82: 84-9.
66. Poynter JN, Jacobs ET, Figueiredo JC, Lee WH, Conti DV, Campbell PT, et al. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010;19:525-36.
67. Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, et al. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:2540-8.
68. Ochs-Balcom HM, Cicek MS, Thompson CL, Tucker TC, Elston RC, S JP, et al. Association of vitaminDreceptor gene variants, adiposity and colon cancer. Carcinogenesis 2008;29:1788-93.
69. Park K, Woo M, Nam J, Kim JC. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. Cancer Lett 2006;237: 199-206.
70. Wong HL, Seow A, Arakawa K, Lee HP, Yu MC, Ingles SA. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 2003;24:1091-5.
71. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003-16.
72. Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med 2008;5:e177.
73. Hiraki LT, Major JM, Chen C, Cornelis MC, Hunter DJ, Rimm EB, et al. Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genet Epidemiol 2013;37:92-8.
74. Theodoratou E, Palmer T, Zgaga L, Farrington SM, McKeigue P, Din FV, et al. Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin d on colorectal cancer risk: A mendelian randomization analysis. PLoS ONE 2012;7:e37662.
75. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007;39:645-9.
76. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009;85:679-91.